Market revenue in 2023 | USD 1,994.9 million |
Market revenue in 2030 | USD 3,502.0 million |
Growth rate | 8.4% (CAGR from 2023 to 2030) |
Largest segment | Clinical |
Fastest growing segment | Pre-Clinical |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Key market players worldwide | Icon PLC, Charles River Laboratories International Inc, IQVIA Holdings Inc, GVK Biosciences, Labcorp Holdings Inc, Thermo Fisher Scientific Inc, PAREXEL, Dassault Systemes SE, Pharmaron Beijing Co Ltd Ordinary Shares - Class H, SGS AG, Worldwide Clinical Trials, Wuxi AppTec Co Ltd, Caidya |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract research organization market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 75.82% in 2023. Horizon Databook has segmented the South Korea healthcare contract research organization market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea has emerged as a leading destination for clinical trials in Asia due to its top-notch medical infrastructure and a highly educated, relatively healthy, and affluent population.
The Korean Ministry of Food & Drug Safety, previously known as the Korean FDA, is the primary regulatory body that oversees medical devices, drugs, food, and cosmetic products.
The government’s efforts to establish a robust clinical trial environment are expected to drive the demand for clinical trial application services, contributing to market growth. Multiple collaborations between industry players are set to make South Korea a lucrative market for healthcare CROs.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea healthcare contract research organization market , including forecasts for subscribers. This country databook contains high-level insights into South Korea healthcare contract research organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account